Zai Lab (ZLAB) Common Equity (2016 - 2026)
Zai Lab's (ZLAB) quarterly Common Equity came in at $662.0 million in Q1 2026, down 18.35% year-on-year from $810.8 million in Q1 2025, and down 7.48% quarter-over-quarter from $715.5 million in Q4 2025.
Zai Lab (ZLAB) Common Equity (2016 - 2026) Analysis & Trends
Zai Lab has disclosed Common Equity across 11 years of filings, most recently posting $662.0 million for Q1 2026.
- Common Equity for Q1 2026 came in at $662.0 million, down 18.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $662.0 million (down 18.35% YoY), and the FY2025 annual result was $715.5 million, down 14.91% from the prior year.
- Common Equity came in at $662.0 million for Q1 2026 at Zai Lab, down from $715.5 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $1.3 billion in Q1 2022 to a low of $662.0 million in Q1 2026.
- The 5-year median for Common Equity is $810.8 million (2025), against an average of $882.2 million.
- Peak annual rise in Common Equity reached 29.55% in 2022, while the deepest fall reached 30.36% in 2022.
- Zai Lab's Common Equity stood at $1.0 billion in 2022, then dropped by 23.86% to $796.1 million in 2023, then increased by 5.62% to $840.9 million in 2024, then dropped by 14.91% to $715.5 million in 2025, then retreated by 7.48% to $662.0 million in 2026.
- The last three Common Equity figures came in at $662.0 million (Q1 2026), $715.5 million (Q4 2025), and $759.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 661.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 661.98 Mn |
| Dec 31, 2025 | 715.50 Mn |
| Sep 30, 2025 | 759.95 Mn |
| Jun 30, 2025 | 791.74 Mn |
| Mar 31, 2025 | 810.75 Mn |
| Dec 31, 2024 | 840.90 Mn |
| Sep 30, 2024 | 667.67 Mn |
| Jun 30, 2024 | 704.18 Mn |
| Mar 31, 2024 | 762.17 Mn |
| Dec 31, 2023 | 796.12 Mn |
| Sep 30, 2023 | 880.98 Mn |
| Jun 30, 2023 | 932.31 Mn |
| Mar 31, 2023 | 1.00 Bn |
| Dec 31, 2022 | 1.05 Bn |
| Sep 30, 2022 | 1.11 Bn |
| Jun 30, 2022 | 1.21 Bn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | 1.38 Bn |
| Sep 30, 2021 | 1.59 Bn |
| Jun 30, 2021 | 1.67 Bn |